🔗 Visit the ClinicalTrials.gov page for NCT00994500
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer. | Immunol Cell Biol | 2011 | 1.05 |
| 2 | A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes. | Neuro Oncol | 2013 | 0.96 |
| 3 | A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma. | Front Oncol | 2013 | 0.95 |
| 4 | The rationale for targeted therapies in medulloblastoma. | Neuro Oncol | 2013 | 0.92 |
| 5 | Medulloblastoma development: tumor biology informs treatment decisions. | CNS Oncol | 2015 | 0.78 |
| 6 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |